{"id":568,"date":"2025-06-29T16:35:43","date_gmt":"2025-06-29T16:35:43","guid":{"rendered":"https:\/\/www.saiep-paris.fr\/?p=568"},"modified":"2026-10-30T22:38:09","modified_gmt":"2026-10-30T22:38:09","slug":"the-2024-china-pharmaceutical-industry-development-conference-and-shanghai-international-biopharmaceutical-industry-week-open-in-shanghai-chen-jining-jin-zhuanglong-and-zeng-yixin-deliver-remarks-g","status":"publish","type":"post","link":"https:\/\/www.saiep-paris.fr\/en\/the-2024-china-pharmaceutical-industry-development-conference-and-shanghai-international-biopharmaceutical-industry-week-open-in-shanghai-chen-jining-jin-zhuanglong-and-zeng-yixin-deliver-remarks-g.html","title":{"rendered":"The 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week Open in Shanghai! Chen Jining, Jin Zhuanglong and Zeng Yixin Deliver Remarks, Gong Zheng Presides"},"content":{"rendered":"<p>The 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week opened this morning (November 16) at the Shanghai Zhangjiang Science Hall. Chen Jining, Secretary of the Municipal Party Committee; Jin Zhuanglong, Minister of Industry and Information Technology; and Zeng Yixin, Deputy Director of the National Health Commission, attended the opening ceremony and delivered remarks; Gong Zheng, Deputy Secretary of the Municipal Party Committee and Mayor, presided over the opening ceremony.<\/p>\n<section>\n<section>\n<section>\n<section>\n<p><strong>The 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week opened this morning (November 16) at the Shanghai Zhangjiang Science Hall. Chen Jining, Secretary of the Municipal Party Committee; Jin Zhuanglong, Minister of Industry and Information Technology; and Zeng Yixin, Deputy Director of the National Health Commission, attended the opening ceremony and delivered remarks; Gong Zheng, Deputy Secretary of the Municipal Party Committee and Mayor, presided over the opening ceremony.<\/strong><\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<section>\n<section><\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<p>\u00a0<\/p>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<p><strong>Focusing on implementing a new round of the \u201cShanghai Plan\u201d for biomedicine, accelerating the whole process and empowering the entire chain \u2014 from basic research, incubation and transformation, clinical trials, review and approval, and production launch to promotion and application \u2014 in a bid to build a world-class biopharmaceutical industry cluster<\/strong><\/p>\n<p>\u00a0<img referrerpolicy=\"no-referrer\" decoding=\"async\" src=\"https:\/\/www.saiep-paris.fr\/wp-content\/uploads\/2026\/11\/WX20250629-1836522x.jpg\" alt=\"\" \/><\/p>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<p>\u00a0<\/p>\n<p>Chen Jining noted that Shanghai is an important birthplace of China&#8217;s modern pharmaceutical industry; that President Xi Jinping personally oversaw Shanghai&#8217;s development of biomedicine and two other leading industries and required continuous improvement of the industrial base capacity and the level of the industrial chain; and that the Third Plenary Session of the 20th CPC Central Committee made strategic arrangements for improving the mechanisms supporting the development of innovative drugs and medical devices, refining policies for the development of industries such as biomedicine, and promoting the opening-up of the medical field. Shanghai will focus on implementing a new round of the \u201cShanghai Plan\u201d for biomedicine, take further comprehensive deepening of reform as a powerful driving force, accelerate the whole process and empower the entire chain \u2014 from basic research, incubation and transformation, clinical trials, review and approval, and production launch to promotion and application \u2014 strive to build a world-class biopharmaceutical industry cluster, and make greater contributions to promoting the innovative development of biomedicine and improving health protection for all humanity. It will strengthen the innovation drive, aim at the frontiers of life sciences, deepen its cultivation of new tracks and new fields, support high-risk, high-value basic research and build a globally leading source of biotechnological innovation. It will adapt to the new changes in research paradigms, accelerate the development of AI drugs and AI medicine, vigorously cultivate more original innovative drugs, build an \u201caccelerator\u201d for clinical trials and clear the \u201cfast lane\u201d for transformation and application. It will strengthen the leadership of reform, deepen the coordinated reform and collaborative governance of medical care, medical insurance and pharmaceuticals, provide greater market space for innovative products, further reduce the overall cost of the industry and empower enterprises in their development. It will strengthen opening-up and cooperation, keep product development oriented toward the global market, align clinical trials with international standards in sync and in quality, support more innovative pharmaceutical enterprises in deeply integrating into the global innovation chain and industrial chain, and serve as a bellwether for expanding high-level opening-up.<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section><\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<p><strong>Promoting the deep integration of scientific and technological innovation with industrial innovation, accelerating the building of a modern pharmaceutical industrial system, comprehensively improving the level of supply assurance, and better meeting the health needs of the broad masses<\/strong><\/p>\n<p>\u00a0<\/p>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<p>Jin Zhuanglong noted that the Ministry of Industry and Information Technology will thoroughly study and implement the important instructions of General Secretary Xi Jinping on the development of the pharmaceutical industry, earnestly implement the arrangements of the Third Plenary Session of the 20th CPC Central Committee and the National Conference on Promoting New-Type Industrialization, and, taking as its starting point the implementation of the Action Plan for the High-Quality Development of the Pharmaceutical Industry (2023-2025) and the Action Plan for the High-Quality Development of the Medical Equipment Industry (2023-2025), promote the deep integration of scientific and technological innovation with industrial innovation, accelerate the building of a modern pharmaceutical industrial system, comprehensively improve the level of supply assurance and better meet the health needs of the broad masses. It will step up scientific and technological innovation in the pharmaceutical industry, improve the collaborative R&amp;D system linking industry, academia, research and medicine, coordinate efforts to fill gaps and strengthen weak links in the chain, and cultivate and develop new quality productive forces. It will promote the transformation and upgrading of the pharmaceutical industry, adhere to high-end, intelligent and green development, thoroughly implement the action for the digital and intelligent transformation of the pharmaceutical industry, cultivate world-class pharmaceutical enterprises and build high-end pharmaceutical industry clusters with global influence. It will enhance pharmaceutical production and supply capacity, improve the national pharmaceutical reserve system and effectively meet the needs of public health emergencies and public medication. It will further expand opening-up and cooperation in the pharmaceutical industry, create a first-class, market-oriented, law-based and internationalized business environment, attach equal importance to traditional Chinese and Western medicine, promote the inheritance, innovation and development of traditional Chinese medicine and its high-quality \u201cgoing global\u201d, and contribute more Chinese solutions to human health.<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<section>\n<section><\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<section>\n<p><strong>Strengthening coordination between scientific and technological innovation and the policies and mechanisms of the medical service system, medical insurance payment mechanisms, drug regulation and the pharmaceutical system, and jointly advancing the development of new quality productive forces in the health sector<\/strong><\/p>\n<p>\u00a0<\/p>\n<p><strong>Zeng Yixin noted that the Third Plenary Session of the 20th CPC Central Committee comprehensively deployed a series of important reform measures to \u201cbuild institutional mechanisms supporting comprehensive innovation, deepen the reform of the medical and health system, and improve the mechanisms supporting the development of innovative drugs and medical devices\u201d. The National Health Commission will fully implement the decisions and arrangements of the Third Plenary Session, give full play to the supporting and driving role of scientific and technological innovation in the innovative development of the pharmaceutical sector, take major science and technology programs and policy coordination as its starting point, encourage application-oriented basic research, frontier technologies, clinical research and demonstration and promotion, and strive to achieve all-round improvement in the output of major original results, breakthroughs in key core technologies, and the building of talent systems and R&amp;D platforms. Focusing on the integration of the innovation chain and the policy chain, it will strengthen coordination between scientific and technological innovation and the policies and mechanisms of the medical service system, medical insurance payment mechanisms, drug regulation and the pharmaceutical system, promote a policy system supporting the entire innovation chain, jointly advance the development of new quality productive forces in the health sector, and better support the realization of the goals of a Healthy China and a strong country in science and technology.<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Marwan Fathallah, Global Chief Executive Officer of the Drug Information Association, delivered remarks at the opening ceremony.<\/p>\n<p>\u00a0<\/p>\n<p>At the opening ceremony, the outstanding progress in industrial upgrading of the pharmaceutical industry during the 14th Five-Year Plan period and the key areas for the future development of industrial technology were released, and a signing ceremony was held for the National Excellence Engineer Practice Base (digital technology field) \u2014 joint training of digital engineers for the pharmaceutical industry. Representatives of Chinese and foreign pharmaceutical enterprises jointly launched a global cooperation and development initiative for the pharmaceutical industry on site.<\/p>\n<p>\u00a0<\/p>\n<p><img referrerpolicy=\"no-referrer\" decoding=\"async\" src=\"https:\/\/www.saiep-paris.fr\/wp-content\/uploads\/2026\/11\/WX20250629-1837242x.jpg\" alt=\"\" \/><\/p>\n<p>\u00a0<\/p>\n<p>Before the opening ceremony, Chen Jining, Jin Zhuanglong, Zeng Yixin, Gong Zheng and Chinese and foreign guests visited the exhibition of typical cases of global cooperation in the pharmaceutical industry.<\/p>\n<p>\u00a0<\/p>\n<p>Municipal leaders Li Zheng and Liu Duo, Ding Kuiling, President of Shanghai Jiao Tong University, Nobel laureate Edvard Moser, and responsible officials of relevant national ministries and commissions attended the opening ceremony. Also attending were responsible officials of relevant Shanghai municipal departments, Chinese and foreign experts and scholars in the pharmaceutical field, and representatives of pharmaceutical enterprises and investment institutions.<\/p>\n<p>\u00a0<\/p>\n<p>From November 16 to 18, the 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week are held concurrently for the first time. Under the theme \u201cCo-creation, Sharing and Win-Win: Joining Hands for a New-Quality Future\u201d, the Conference and Industry Week adopt the \u201c1+16+1+N\u201d format: one opening ceremony and main forum, 16 series of thematic events, one exhibition of typical cases of global cooperation in the pharmaceutical industry, and N series of themed events during Industry Week; through results releases, thematic sharing, policy interpretation and roundtable forums, they focus on frontier technological innovation in China&#8217;s pharmaceutical industry and on global pharmaceutical cooperation, bring together forces from government, industry, academia, research, medicine, application and finance, jointly explore new paths for the pharmaceutical industry, promote the cultivation of new quality productive forces and the development of future industries, and advance the development of global health.<\/p>\n<p>\u00a0<\/p>\n<p><img referrerpolicy=\"no-referrer\" decoding=\"async\" src=\"https:\/\/www.saiep-paris.fr\/wp-content\/uploads\/2026\/11\/WX20250629-1837302x.jpg\" alt=\"\" \/><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<section data-mpa-template=\"t\">\n<section>\n<p>Source: Shanghai Release<\/p>\n<p>Editor: Lan Yue<\/p>\n<\/section>\n<section data-mpa-template=\"t\">\n<section data-mpa-template=\"t\">\n<section>\n<section>\n<section>\n<section>\n<section data-mpa-template=\"t\">\n<section data-mpa-template=\"t\">\n<section data-mpa-template=\"t\">\n<section data-mpa-template=\"t\">\n<section>\n<section>\n<section>\n<section>\n<section><\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>The 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week opened this morning (November 16) at the Shanghai Zhangjiang Science Hall. Chen Jining, Secretary of the Municipal Party Committee; Jin Zhuanglong, Minister of Industry and Information Technology; and Zeng Yixin, Deputy Director of the National Health Commission, attended the opening ceremony and delivered remarks; Gong Zheng, Deputy Secretary of the Municipal Party Committee and Mayor, presided over the opening ceremony. The 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biopharmaceutical Industry Week opened this morning (November [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-568","post","type-post","status-publish","format-standard","hentry","category-news-and-trends"],"_links":{"self":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/comments?post=568"}],"version-history":[{"count":2,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/568\/revisions"}],"predecessor-version":[{"id":2547,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/posts\/568\/revisions\/2547"}],"wp:attachment":[{"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/media?parent=568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/categories?post=568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.saiep-paris.fr\/en\/wp-json\/wp\/v2\/tags?post=568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}